Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of Topical Glucosamine Cream in Knee Osteoarthritis
NCT03743896Phase 4Completed
- Sponsor
- Lynk Biotechnologies Pte Ltd
- Start
- May 2016
- Primary completion
- Mar 2017
- Countries
- 1
01
Overview
Phase 4, open-label trial of glucosamine sulphate in osteoarthritis (OA), sponsored by Lynk Biotechnologies Pte Ltd. Primary endpoint: Concentration of glucosamine in synovial fluid. Started May 2016; status: completed.
02
Drugs
glucosamine sulphate
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT03743896.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03743896.